What does this research mean for the field?

There is no apparent causality between glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposure and suicidality. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To investigate the potential association between glucagon-like peptide-1 receptor agonist exposure and suicidality.

March 8, 2026

Association of Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.

View Full Paper

Ask AI

Bookmark

Authors

HAHezekiah C T Au YZYang Jing ZhengUniversity of Toronto GLGia Han Le

Discussion

Member takes

Implication

This systematic review explores the relationship between GLP-1 receptor agonists and suicidality, suggesting no clear causality exists.

Key Points

To investigate the potential association between glucagon-like peptide-1 receptor agonist exposure and suicidality.
Conducted a systematic review of existing reports
Analyzed data regarding GLP-1 receptor agonists
Evaluated reported incidences of suicidality
No clear causality between GLP-1 receptor agonists and suicidality was established
Reports on suicidality in relation to GLP-1 receptor agonists exist but lack definitive conclusions

Cite This Study

Au et al. (2026) studied this question.

synapsesocial.com/papers/69ada8cfbc08abd80d5bc2c7 https://doi.org/10.1111/obr.70120

View Full Paper

Ask AI

Bookmark

Association of Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.

Discussion

Member takes

Implication

Key Points

Cite This Study

Association of Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider